PCOR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
PCOR is not a good buy right now. Despite being extremely oversold (RSI_6 ~12) and likely due for a technical bounce, the broader trend is decisively bearish (SMA_200 > SMA_20 > SMA_5 and a negatively expanding MACD histogram). With no proprietary buy signals today and statistically weak forward bias (notably negative 1-week/-1-month pattern projections), the higher-probability outcome for an impatient buyer is further downside or choppy action rather than a clean rebound you can confidently buy today.
Price/Trend: Pre-market ~56.34 (-0.79%) sits below S1 (58.37) and is hovering closer to S2 (54.43), indicating the stock has already broken an important support zone and is probing the next support. Momentum: MACD histogram -1.088 and negatively expanding = downside momentum is still accelerating. Overbought/Oversold: RSI_6 at 12.07 = deeply oversold, which increases odds of a short-term snapback, but oversold alone is not a buy signal when trend/momentum are still deteriorating. Moving Averages: Bearish stack (SMA_200 > SMA_20 > SMA_5) confirms a persistent downtrend. Key Levels: Support ~54.43 (S2). Near-term resistance ~58.37 (S1) then ~64.74 (pivot). For a higher-quality entry, price should reclaim and hold at least S1/pivot with improving momentum.
Intellectia Proprietary Trading Signals
on 2026-02-12 after hours could act as a catalyst if guidance/margins surprise positively.
Technical breakdown: trading below S1 with bearish MA stack and worsening MACD increases risk of continued drift toward/through S2 (~54.43).
Pattern-based forward view provided: higher probability of weakness over 1-week (-2.69%) and 1-month (-9.95%) horizons.
Earnings risk on 2026-02-12: with the stock already weak, any miss or cautious guidance could accelerate downside.
Profitability still not established (latest quarter remains loss-making), which can be punished in risk-off tape (S&P500 pre-market -0.39%).
Latest reported quarter: 2025/Q3. Growth: Revenue 338.851M, +14.52% YoY (solid top-line growth). Profitability: Net income -9.101M (more negative YoY, -65.51%); EPS -0.06 (worse YoY, -66.67%). Margins: Gross margin 79.71%, down ~2.11% YoY. Read-through: The company is still growing well, but profitability and gross margin weakened in the latest quarter—fundamentals don’t currently provide a clean ‘buy-the-dip’ justification while the chart is breaking down.
Recent trend: Analyst stance has strengthened meaningfully with multiple price-target increases and upbeat reiterations following Q3, plus a notable upgrade. Key changes: Barclays upgraded to Overweight (2026-01-05) with PT $90 (from $82). BTIG initiated Buy with PT $88 (2025-12-16). Several firms raised PTs on 2025-11-06 (Baird $93, Piper $91, Canaccord $90, TD Cowen $90, BMO $87, Stifel $85) while maintaining bullish ratings. Wall Street pros: improving GTM execution, strong large-deal traction, margin expansion trajectory, and potential multi-year demand tailwind as construction improves post-rate cuts. Wall Street cons: at least some tempering around the pace of 2026 acceleration (e.g., Canaccord), and the stock’s current price action is not confirming the bullish thesis yet. Influential/Political flows: No recent congress trading data available; hedge funds and insiders show neutral recent trends.
